Second-Generation Antipsychotics Just as Likely as Older Drugs to Cause EPS

1
1908

In a study of an earlier randomized controlled trial of antipsychotics, researchers from Yale and the U.K found that second-generation antipsychotics were as likely as the first-generation antipsychotics to cause extrapyramidal symptoms. However, patients in the second-generation group were “dramatically” (30-fold) less likely to be prescribed medication for the management of these side effects. First-generation antipsychotics have the potential to “avoid life-shortening metabolic disturbances” caused by second-generation antipsychotics, but current psychiatrists have little or no experience with the prior generation of antipsychotics, the researchers said. Results will appear in the British Journal of Psychiatry.

Article → 

***

Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.

Previous articleAztraZeneca Struggling as Generic Seroquel Gets the Green Light
Next articleHas Psychiatry Chosen to Ignore the Hippocratic Oath?
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected]

1 COMMENT

LEAVE A REPLY